CD44 and breast carcinoma: Approximately 15% of breast cancers are estrogen receptor (ER)-negative, high-grade and often basal-like breast cancer that are enriched in cells expressing putative stem cell markers CD44+/CD24−[6] and over-expresses genes associated with embryonic stem cell gene signatures [7].